NCT05931224

Clinical Trial to Evaluate the Efficacy and Safety of D064 and D702 Combination Therapy

A Randomized, Double-blind, Multi-center, Therapeutic Confirmatory, Phase 3 Trial To Evaluate the Efficacy and Safety of D064 and D702 Combination Therapy Versus D660 Monotherapy in Essential Hypertension Patients

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 346 (actual)
• Sponsor: Chong Kun Dang Pharmaceutical · Industry
• Sex: All
• Age: 19 Years
• Healthy volunteers: Not accepted

Summary

Clinical Trial to Evaluate the Efficacy and Safety of D064 and D702 Combination Therapy

Conditions

• Essential Hypertension

Interventions

Type	Name	Description
DRUG	D064, D702, placebo of D660	Experimental Group Subjects assigned to this group are treated with D064, D702, placebo of D660
DRUG	D660, placebo of D064, placebo of D702	Experimental Group Subjects assigned to this group are treated with D660, placebo of D064, placebo of D702

Timeline

• Start date: 2023-06-28
• Primary completion: 2024-05-13
• Completion: 2024-05-13
• First posted: 2023-07-05
• Last updated: 2024-06-04

Locations

1 site across 1 country: South Korea